1. Home
  2. AIRI vs AIMD Comparison

AIRI vs AIMD Comparison

Compare AIRI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Industries Group

AIRI

Air Industries Group

HOLD

Current Price

$2.70

Market Cap

14.9M

Sector

Industrials

ML Signal

HOLD

Logo Ainos Inc.

AIMD

Ainos Inc.

HOLD

Current Price

$1.97

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRI
AIMD
Founded
1979
1984
Country
United States
United States
Employees
N/A
41
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
13.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AIRI
AIMD
Price
$2.70
$1.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
51.2K
43.3K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
N/A
EPS
N/A
N/A
Revenue
$47,921,000.00
N/A
Revenue This Year
$6.43
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$1.26
52 Week High
$3.95
$4.50

Technical Indicators

Market Signals
Indicator
AIRI
AIMD
Relative Strength Index (RSI) 25.42 49.58
Support Level $2.55 $1.68
Resistance Level $3.31 $1.98
Average True Range (ATR) 0.07 0.17
MACD -0.03 0.00
Stochastic Oscillator 13.75 30.51

Price Performance

Historical Comparison
AIRI
AIMD

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: